U.S. Supreme Court: A naturally occurring DNA segment is Not Patentable

In its unanimous decision in the case of Association for Molecular Pathology v. Myriad Genetics, Inc., the United States Supreme Court held: A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but cDNA is patent eligible because it is not naturally occurring.
Contributor
Robin Mashal
Los Angeles, California
Commercial Litigation
(310) 286-2000

About
I am a litigation lawyer, licensed to practice law in the State of California. You can reach me by phone at (310) 286-2000.